| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/BMJ.318.7176.96 |
| P8608 | Fatcat ID | release_xjluqkze6bh5xfrtgsx5yyl4pi |
| P932 | PMC publication ID | 27684 |
| P698 | PubMed publication ID | 9880284 |
| P5875 | ResearchGate publication ID | 13409259 |
| P50 | author | Valerie Beral | Q4793379 |
| P2093 | author name string | S Darby | |
| P Hannaford | |||
| C Hermon | |||
| C Kay | |||
| G Reeves | |||
| P2860 | cites work | Incidence of arterial disease among oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study | Q71770240 |
| Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception | Q73296681 | ||
| Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies | Q28280957 | ||
| Comparison of cause of death coding on death certificates with coding in the Royal College of General Practitioners Oral Contraception Study | Q33684154 | ||
| Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study | Q34339315 | ||
| Effects of changes in smoking status on risk estimates for myocardial infarction among women recruited for the Royal College of General Practitioners' Oral Contraception Study in the UK. | Q35558397 | ||
| Mortality among oral contraceptive users: 20 year follow up of women in a cohort study | Q35719637 | ||
| Cohort study analysis with a FORTRAN computer program. | Q38520032 | ||
| A long-term follow-up study of women using different methods of contraception--an interim report | Q44079961 | ||
| Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception | Q71396287 | ||
| P433 | issue | 7176 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | birth control | Q122224 |
| P304 | page(s) | 96-100 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study | |
| P478 | volume | 318 |
| Q34057720 | Breast cancer hypothesis: a single cause for the majority of cases |
| Q31128167 | Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study |
| Q31035317 | Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies |
| Q43474119 | Cohort studies: marching towards outcomes |
| Q36845040 | Combined hormonal contraception and venous thromboembolism |
| Q73328312 | Contraception |
| Q36203486 | Contraception during perimenopause |
| Q36542363 | Contraception for the older woman: an update |
| Q74301201 | Dangers of suppressing menstruation |
| Q36903745 | Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris |
| Q58024050 | Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study |
| Q52936191 | Evaluating the safety of medicines, with particular reference to contraception. |
| Q35979358 | Evidence about extending the duration of oral contraceptive use to suppress menstruation |
| Q36311502 | Hereditary breast and ovarian cancer: review and future perspectives |
| Q34131588 | Hormonal contraception and breast cancer risk |
| Q34120493 | Hormonal contraception and risk of cancer. |
| Q94189071 | Is primary care research a lost cause? |
| Q43945043 | Long-term effects of combined oral contraceptives on markers of endothelial function and lipids in healthy premenopausal women |
| Q57560381 | Long-term effects of oral contraceptives on ovarian cancer risk |
| Q38579398 | Meta-analysis of oral contraceptive use and risks of all-cause and cause-specific death. |
| Q24629702 | Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study |
| Q43976686 | Mortality among oral contraceptive users: an evolving story. |
| Q33816381 | Mortality associated with oral contraceptive use. Confounding might have accounted for results |
| Q34217740 | Mortality in relation to oral contraceptive use and cigarette smoking |
| Q53500683 | Nuisance or natural and healthy: should monthly menstruation be optional for women? |
| Q34086042 | Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms |
| Q90582026 | Oral Contraceptive Use and Increased Risk of Stroke: A Dose-Response Meta-Analysis of Observational Studies |
| Q73314410 | Oral contraception and cardiovascular risk factors during adolescence |
| Q42760071 | Oral contraception and health |
| Q37019747 | Oral contraceptive pills: A risk factor for retinal vascular occlusion in in-vitro fertilization patients |
| Q28363574 | Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study |
| Q34435123 | Oral contraceptive use and mortality after 36 years of follow-up in the Nurses' Health Study: prospective cohort study |
| Q34305820 | Oral contraceptive use and risk of breast cancer: a meta-analysis of prospective cohort studies |
| Q100755293 | Oral contraceptive use and risk of suicidal behavior among young women |
| Q24800615 | Oral contraceptive use before first birth and risk of breast cancer: a case control study |
| Q53329164 | Oral contraceptive use, hormone replacement therapy, reproductive history and risk of colorectal cancer in women. |
| Q34417633 | Oral contraceptives and cancer: an update |
| Q47912543 | Oral contraceptives and colorectal cancer |
| Q36622718 | Oral contraceptives and colorectal cancer risk: a meta-analysis |
| Q34039832 | Oral contraceptives and stroke |
| Q34476733 | Oral contraceptives: an update on health benefits and risks. |
| Q94700372 | Ovarian cancer and oral contraceptives |
| Q31147531 | Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls |
| Q36201263 | Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies |
| Q44141628 | Ovarian cancer in Ibadan: characteristics and management |
| Q38090489 | Ovarian epithelial tumors and reproductive factors: a systematic review |
| Q34920011 | Perimenopausal use of reproductive hormones effects on breast and endometrial cancer |
| Q96961742 | Pille, Depression und Suizid – ein Statement aus kinder- und jugendpsychiatrischer und gynäkologischer Sicht |
| Q28394485 | Population-based trends in lung cancer incidence in women |
| Q33959816 | Prophylactic oophorectomy: clinical considerations |
| Q45025106 | Prospective cohort study of the association between use of low-dose oral contraceptives and stroke in Chinese women |
| Q36694868 | Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: the Norwegian-Swedish Women's Lifestyle and Health Cohort Study |
| Q34575924 | Risk of cancer development in relation to oral contraception |
| Q33723561 | Risk-reducing strategies for women carrying brca1/2 mutations with a focus on prophylactic surgery |
| Q33748064 | Science, medicine, and the future. Contraception |
| Q59238524 | Screening for ovarian cancer |
| Q44424791 | Synthesis and Evaluation of B-, C-, and D-Ring-Substituted Estradiol Carboxylic Acid Esters as Locally Active Estrogens |
| Q40626880 | Termination of pregnancy following panic-stopping of oral contraceptives |
| Q24791125 | The Million Women Study: design and characteristics of the study population. The Million Women Study Collaborative Group |
| Q42932431 | The contraceptive revolution: some excellent progress but work still to be done |
| Q34613896 | The contribution of cohort studies to prescribing research. |
| Q34039806 | The place of combined oral contraceptives in contraception |
| Q73727288 | The relationship between use of oral contraceptives and myocardial infarction in young women with fatal outcome, compared to those who survive: results from the MICA case-control study |
| Q33727605 | The science, medicine, and future of contraception |
| Q46921099 | Use of oral contraceptives and mortality during 14 years' follow-up of Norwegian women |
| Q37975229 | Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis |
| Q73443981 | [Factors associated with weight gain in women using oral contraceptives: results of a French 2001 opinion poll survey conducted on 1665 women] |
Search more.